Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 35Gastrointestinal 31Genitourinary 20Gynecologic 16Head & Neck 13Dermatologic 10Breast 9Lymphoid 4Other solid neoplasm 3Endocrine 2Sarcoma 1NET 1CNS 1

Conditions

Lymphoma 551Precursor Cell Lymphoblastic Leukemia-Lymphoma 511Lymphoma, Non-Hodgkin 439Lymphoma, Follicular 407Lymphoma, Large B-Cell, Diffuse 392Leukemia, Lymphocytic, Chronic, B-Cell 392Lymphoma, B-Cell 249Lymphoma, Mantle-Cell 224Hodgkin Disease 209Recurrence 206Leukemia, Myeloid, Acute 199Leukemia 197Multiple Myeloma 186Burkitt Lymphoma 185Lymphoma, B-Cell, Marginal Zone 170Neoplasms 153Myelodysplastic Syndromes 134Hematologic Neoplasms 115Waldenstrom Macroglobulinemia 103Lymphoma, T-Cell, Peripheral 86Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 83Lymphoma, T-Cell 82Lymphoma, T-Cell, Cutaneous 67Leukemia, Myelogenous, Chronic, BCR-ABL Positive 63Mycosis Fungoides 57Leukemia, Biphenotypic, Acute 55Breast Neoplasms 55Leukemia, B-Cell 52Myeloproliferative Disorders 50Lymphoproliferative Disorders 47

Interventions

pembrolizumab 4Gemcitabine 1Brentuximab Vedotin 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body × Lymphoid × 1 year × Clear all
NCT02684292 2026-02-18

MK-3475-204

Merck Sharp & Dohme LLC

Phase 3 Completed
304 enrolled 1 FDA
Lymphoid

Parkinson Disease 4, Autosomal Dominant Lewy Body, Hodgkin Disease

NCT03598608 2026-02-05

MK-4280-003

Merck Sharp & Dohme LLC

Phase 1/2 Completed
137 enrolled
Lymphoid

Parkinson Disease 4, Autosomal Dominant Lewy Body, Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT05508867 2026-01-20

MK-4280A-008

Merck Sharp & Dohme LLC

Phase 2 Completed
203 enrolled
Lymphoid

Parkinson Disease 4, Autosomal Dominant Lewy Body, Hodgkin Disease

NCT03010176 2025-10-29

MK-1454-001

Merck Sharp & Dohme LLC

Phase 1 Completed
156 enrolled 20 charts
Lymphoid

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡